|
EIF5A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19519974315108E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55790000000633E-05 |
| Normal-vs-Stage2 |
4.951700E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
5.238800E-03 |
| Stage1-vs-Stage2 |
4.220600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.318000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
1.508560E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.62220003675185E-09 |
| Normal-vs-AfricanAmerican |
2.49909999999742E-05 |
| Normal-vs-Asian |
1.179990E-01 |
| Caucasian-vs-AfricanAmerican |
6.558800E-01 |
| Caucasian-vs-Asian |
8.224800E-01 |
| AfricanAmerican-vs-Asian |
7.736000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.351100E-04 |
| Normal-vs-Female |
3.13650000416388E-08 |
| Male-vs-Female |
2.322400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.836700E-04 |
| Normal-vs-Extreme_Weight |
4.99899999950593E-07 |
| Normal-vs-Obese |
1.322150E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.560600E-01 |
| Normal_Weight-vs-Obese |
3.404600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.925360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.039650E-04 |
| Normal-vs-Age(41-60Yrs) |
1.343600E-03 |
| Normal-vs-Age(61-80Yrs) |
8.57510000007444E-07 |
| Normal-vs-Age(81-100Yrs) |
2.313600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.464200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.553800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.872000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.686200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.541800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.653200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.446800E-01 |
| Normal-vs-Grade 3 |
5.943600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
1.867800E-01 |
| Grade 2-vs-Grade 4 |
6.446800E-01 |
| Grade 3-vs-Grade 4 |
5.943600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.35880004207223E-09 |
| Normal-vs-N1 |
4.148200E-02 |
| N0-vs-N1 |
3.205400E-01 |
|
|
